Dube Eric M

Chief Executive Officer | Chief Executive Officer

1 company

Good

Trades Analyzed

12M Win Rate

47.4%

Avg 3M Return

-0.2%

Avg 12M Return

-17.8%

Dube Eric M is a Chief Executive Officer at Travere Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.

Estimated insider holdings value: $26.0M based on current market prices.

Holdings by Company

TVTXApr 15, 2026

Current Shares440.1K

Value$25.98M

Net Activity-546,846

Bought: 0Sold: 546.8K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 5, 2023	TVTX Travere Therapeutics, Inc.	Chief Executive Officer	Sell	4,455	$14.71	$65,533.05	-1.8%	-55.7%	-29.2%
Feb 1, 2023	TVTX Travere Therapeutics, Inc.	Chief Executive Officer	Sell	8,196	$22.25	$182,361.00	-3.3%	-29.2%	-61.1%
Jan 24, 2023	TVTX Travere Therapeutics, Inc.	Chief Executive Officer	Sell	6,442	$21.50	$138,503.00	-4.2%	-2.9%	-58.3%
Jan 5, 2023	TVTX Travere Therapeutics, Inc.	Chief Executive Officer	Sell	5,625	$20.75	$116,718.75	-3.5%	+1.6%	-57.9%
Feb 10, 2022	TVTX Travere Therapeutics, Inc.	Chief Executive Officer	Sell	4,832	$27.84	$134,522.88	-2.9%	-22.0%	-25.3%
Jan 31, 2022	TVTX Travere Therapeutics, Inc.	Chief Executive Officer	Sell	4,813	$27.40	$131,876.20	-2.8%	-6.4%	-18.5%
Jan 24, 2022	TVTX Travere Therapeutics, Inc.	Chief Executive Officer	Sell	7,873	$24.98	$196,667.54	-5.6%	+9.9%	-16.2%
Jan 5, 2022	TVTX Travere Therapeutics, Inc.	Chief Executive Officer	Sell	17,332	$30.08	$521,406.72	-3.8%	-3.3%	-30.0%
Aug 17, 2021	TVTX Travere Therapeutics, Inc.	Chief Executive Officer	Sell	7,836	$17.12	$134,142.13	-4.8%	+48.9%	+40.8%
Jun 2, 2021	TVTX Travere Therapeutics, Inc.	Chief Executive Officer	Sell	9,562	$14.62	$139,796.98	-3.1%	+52.2%	+58.6%